Regeneron Pharmaceuticals' Non-cash Items fell 550.57% to $326.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $474.0 million, marking a year-over-year increase of 590000.0%. This contributed to the annual value of $474.0 million for FY2025, which is 590000.0% up from last year.
According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Non-cash Items is $326.1 million, which was down 550.57% from $158.7 million recorded in Q3 2025.
In the past 5 years, Regeneron Pharmaceuticals' Non-cash Items ranged from a high of $1.8 billion in Q3 2021 and a low of -$2.5 billion during Q2 2021
In the last 5 years, Regeneron Pharmaceuticals' Non-cash Items had a median value of $125.0 million in 2021 and averaged $40.2 million.
As far as peak fluctuations go, Regeneron Pharmaceuticals' Non-cash Items crashed by 546268.98% in 2021, and later skyrocketed by 59370.53% in 2024.
Regeneron Pharmaceuticals' Non-cash Items (Quarter) stood at $143.5 million in 2021, then skyrocketed by 264.32% to $522.8 million in 2022, then crashed by 113.37% to -$69.9 million in 2023, then soared by 593.71% to $345.1 million in 2024, then dropped by 5.51% to $326.1 million in 2025.
Its last three reported values are $326.1 million in Q4 2025, $158.7 million for Q3 2025, and -$247.2 million during Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value